BioSpace News Archive

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company developing a novel class of T cell engagers, reported financial results for the first quarter ended March 31, 2020 and provided a corporate update.

OraSure Technologies, Inc. announced its financial results for the three months ended March 31, 2020 and provided an update on COVID-19 activities.

TransMedics Group, Inc., a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, reported financial results for the quarter ended March 31, 2020.

ResMed announced that Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Bank of America Securities Healthcare Conference 2020 on Tuesday, May 12, 2020, beginning at approximately 4:20 p.m. via webcast.

Dr. Arnold S. Lippa, Ph.D. to Continue as Executive Chairman of the Board of Directors and Chief Scientific Officer

Analysis Group , a global leader in health economics and outcomes research (HEOR), announced the publication of the first study to quantitatively assess the efficacy and safety evidence of current and emerging treatments for patients with non-muscle-invasive bladder cancer (NMIBC) whose cancer recurred following treatment with Bacillus Calmette

Dow earned the 22nd place on the 2020 DiversityInc Top 50 Companies for Diversity list, which was announced yesterday at a virtual event hosted by DiversityInc.

Titan Medical Inc. (“ Titan ” or the “ Company ”) ( TSX:TMD ) ( Nasdaq:TMDI ), a medical device company focused on the design and development of a single-port robotic surgical system for application in minimally invasive surgery (“ MIS ”), is pleased to announce today that it closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the p

Quantzig, global data analytics and advisory firm, that delivers actionable analytics solutions presents a new case study series that focuses on how coronavirus is impacting businesses across geographies.

Cigna is launching its new COVID-19 Customer Protection Program to further safeguard its customers from unexpected costs for COVID-19 care through “surprise” or “balance” bills from out-of-network health care providers.